Purchase of Two TEG‑6S Thromboelastography Systems from Haemonetics Corporation

The University of New Mexico is seeking a sole‑source procurement of two TEG‑6S thromboelastography systems from Haemonetics Corporation to enable comprehensive blood‑coagulation and clot‑breakdown analysis in rodent trauma models. The purchase is justified on the basis that the TEG‑6S technology is proprietary and uniquely capable of measuring clot breakdown in rats, a capability not available from any competing vendor. This is a one‑time acquisition valued at $71,800 with delivery expected shortly after award. • Quantity: Two TEG‑6S systems (one‑time purchase) • Total value: $71,800 • Sole‑source justification: Only Haemonetics provides the required proprietary technology; competitors (e.g., ROTEM) lack the needed capability • Timeline: Request posted 09/24/2026, award expected 09/25/2026, submission deadline 10/25/2026 • Primary contact: Jack Barry, Accountant II ([email protected], (505) 272‑5745)